Treatment of short bowel syndrome patients with colon-in-continuity
US9597373B2 · kind B2 · utility
0Cited by
6References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2016 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Oct 5, 2036 |
Classification
- Technology area (CPC —)General
Abstract
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.